ZNTL icon

Zentalis Pharmaceuticals
ZNTL

Overview Fund Activity

142 hedge funds and large institutions have $195M invested in Zentalis Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 24 closing their positions.

Holders
142
Holders Change
+6
Holders Change %
+4.41%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
33
Increased
57
Reduced
31
Closed
24
Calls
$229K
Puts
$222K
Net Calls
+$7K
Net Calls Change
+$86K

Top Buyers

1
IHAM
1
Integral Health Asset Management
New York
$3.18M
2
P
2
Pfizer
New York
$2.89M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$3.23M
4
OM
4
Opaleye Management
Massachusetts
$5.36M
5
AC
5
Almitas Capital
California
$4.93M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$552K
2
EAM
2
Eventide Asset Management
Massachusetts
$13.6M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.91M
4
DC
4
Decheng Capital
California
$7.08M
5
Bank of America
5
Bank of America
North Carolina
$654K
Name Market Value Shares Shares
Change 		Shares
Change %
MCMC
1
Matrix Capital Management Company
New Hampshire
$42.3M 13,959,973 – –
EAM
2
Eventide Asset Management
Massachusetts
$13.6M 4,475,054 -4,072,842 -48%
BlackRock
3
BlackRock
New York
$12.8M 4,238,089 -523,084 -11%
Vanguard Group
4
Vanguard Group
Pennsylvania
$9.91M 3,271,240 -1,341,467 -29%
Citadel Advisors
5
Citadel Advisors
Florida
$9.75M 3,216,727 +499,206 +18%
DC
6
Decheng Capital
California
$7.08M 2,338,095 -770,000 -25%
OM
7
Opaleye Management
Massachusetts
$5.36M 1,767,500 +800,500 +83%
Morgan Stanley
8
Morgan Stanley
New York
$5.19M 1,713,188 +101,621 +6%
AC
9
Almitas Capital
California
$4.93M 1,626,896 +665,968 +69%
Primecap Management
10
Primecap Management
California
$4.61M 1,520,630 +22,600 +2%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$3.98M 1,312,964 +20,864 +2%
State Street
12
State Street
Massachusetts
$3.91M 1,288,985 +42,372 +3%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$3.76M 1,239,459 +110,882 +10%
Verition Fund Management
14
Verition Fund Management
Connecticut
$3.69M 1,217,094 -287,226 -19%
MB
15
MPM BioImpact
Massachusetts
$3.35M 1,106,851 -358,950 -24%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$3.23M 1,067,233 +804,017 +305%
IHAM
17
Integral Health Asset Management
New York
$3.18M 1,050,000 +1,050,000 New
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$2.97M 979,855 -57,056 -6%
TCM
19
Tybourne Capital Management
Hong Kong
$2.91M 961,486 – –
Millennium Management
20
Millennium Management
New York
$2.9M 957,563 +71,477 +8%
P
21
Pfizer
New York
$2.89M 953,834 +953,834 New
Goldman Sachs
22
Goldman Sachs
New York
$2.78M 918,107 +284,043 +45%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$2.7M 889,700 -259,700 -23%
JPMorgan Chase & Co
24
JPMorgan Chase & Co
New York
$2.6M 859,710 +370,511 +76%
Nuveen Asset Management
25
Nuveen Asset Management
Illinois
$1.94M 641,407 +167,062 +35%
1
2 3 4 5